Pfizer Says Lower Vaccine Dose Could Also Work for Older Kids

Oct. 26, 2021, 4:31 PM

Pfizer Inc.’s lower-dose Covid-19 vaccine for kids under 12 appears to offer protection across the board, company officials said, and the drug giant may look into offering lower doses for teens who now get the adult dose.

A scientific advisory panel to the Food and Drug Administration is deliberating Tuesday on whether to recommend the vaccine, which Pfizer makes with partner BioNTech SE, for 5- to 11-year-olds. If cleared by regulators, it would make a Covid-19 vaccine available to all school-age children for the first time.

The proposed pediatric dose is 10 micrograms, or a third of the ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.